Hydroxyurea decreases hospitalizations in pediatric patients with Hb SC and Hb SB+ thalassemia.

Lebensburger, Jeffrey D; Patel, Rakeshkumar J; Palabindela, Prasannalaxmi; Bemrich-Stolz, Christina J; Howard, Thomas H; Hilliard, Lee M.

Afiliação

Lebensburger JD; Division of Pediatric Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.
Patel RJ; Division of Pediatric Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.
Palabindela P; Division of Pediatric Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.
Bemrich-Stolz CJ; Division of Pediatric Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.
Howard TH; Division of Pediatric Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.
Hilliard LM; Division of Pediatric Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.

J Blood Med ; 6: 285-90, 2015.

Article em En | MEDLINE | ID: mdl-26719735